Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

Catholic University of the Sacred Heart

Italy

Country: Italy

Ownership: Private

Established: 1921-01-01

Employees: -

Market Cap: -

Website: http://www.ucsc.it

Clinical Trials

Micro-laparoscopy and Single-port Hysterectomy

Not Applicable

Completed

Conditions: Pain, Postoperative

Interventions: Procedure: micro-laparoscopy
Procedure: Laparoendoscopic single site surgery

First Posted Date: 2012-08-16

Last Posted Date: 2012-08-16

Lead Sponsor: Catholic University of the Sacred Heart

Target Recruit Count: 71

Registration Number: NCT01666483

Locations: 🇮🇹
Francesco Fanfani, Rome, Italy

Preoperative Downstaging of Extraperitoneal T3 Rectal Cancer: XELOXRT Versus XELACRT. A Multicenter, Phase III Study

Phase 3

Conditions: Rectal Cancer

Interventions: Drug: XELOX RT
Drug: XELAC RT

First Posted Date: 2012-07-31

Last Posted Date: 2012-07-31

Lead Sponsor: Catholic University of the Sacred Heart

Target Recruit Count: 616

Registration Number: NCT01653301

Locations: 🇮🇹
Catholic University of Sacred Heart, Rome, Italy

Effect of Remifentanil on Postoperative Cognition Function in Patients Undergoing Major Abdominal Surgery

Phase 4

Completed

Conditions: Patients Undergoing Major Abdominal Surgery
Postoperative Confusion

Interventions: Drug: Remifentanil
Drug: Fentanyl

First Posted Date: 2012-06-26

Last Posted Date: 2012-06-26

Lead Sponsor: Catholic University of the Sacred Heart

Target Recruit Count: 622

Registration Number: NCT01627873

Locations: 🇮🇹
Policlinico Universitario "A.Gemelli", Rome, Italy

Fluid Optimization in Liver Surgery

Completed

Conditions: Cancer of Liver

First Posted Date: 2012-06-26

Last Posted Date: 2012-06-26

Lead Sponsor: Catholic University of the Sacred Heart

Target Recruit Count: 17

Registration Number: NCT01627808

Locations: 🇮🇹
Catholic University of Sacred heart, Rome, Italy

Highly Purified Menotropin (HP-hMG) Versus Recombinant FSH (rFSH) Plus Recombinant LH (rLH) in Intrauterine Insemination Cycles in Women ≥35 Years: a Prospective Randomized Trial.

Phase 1

Completed

Conditions: Female Infertility

Interventions: Drug: Meropur 150 a day
Drug: Gonal-f 150 plus Luveris 150

First Posted Date: 2012-05-23

Last Posted Date: 2014-09-05

Lead Sponsor: Catholic University of the Sacred Heart

Target Recruit Count: 579

Registration Number: NCT01604044

Locations: 🇮🇹
Policlinico Agostino Gemelli, Rome, Italy

Effects of Drospirenone-ethinylestradiol and/or NOMAC-valerate Estradiol on Cardiovascular Risk in Women With Polycystic Ovary Syndrome

Phase 1

Conditions: Polycystic Ovary Syndrome

Interventions: Drug: Zoely
Drug: Yasmin

First Posted Date: 2012-05-22

Last Posted Date: 2012-05-22

Lead Sponsor: Catholic University of the Sacred Heart

Target Recruit Count: 10

Registration Number: NCT01603745

Locations: 🇮🇹
Catholic university of Sacred Heart, Rome, Italy

Atazanavir/r + Lamivudine Dual Therapy

Phase 4

Completed

Conditions: Human Immunodeficiency Virus

Interventions: Drug: Atazanavir, ritonavir, lamivudine

First Posted Date: 2012-05-16

Last Posted Date: 2019-07-24

Lead Sponsor: Catholic University of the Sacred Heart

Target Recruit Count: 266

Registration Number: NCT01599364

Locations: 🇮🇹
Ospedale S. M. Annunziata - U.O. Malattie Infettive, Bagno a Ripoli, Firenze, Italy
🇮🇹
P.O. "S. Caterina Novella" - UOC di Malattie Infettive, Galatina, Lecce, Italy
🇮🇹
Azienda Ospedaliero Universitaria - Ospedali Riuniti di Ancona Struttura Organizzativa Dipartimentale (S.O.D) Clinica di Malattie infettive, Ancona, Italy

and more 18 locations

Metformin in Pregnancy in Women With Polycystic Ovary Syndrome

Not Applicable

Completed

Conditions: Polycystic Ovary Syndrome

Interventions: Drug: Metformin

First Posted Date: 2012-05-09

Last Posted Date: 2012-05-11

Lead Sponsor: Catholic University of the Sacred Heart

Target Recruit Count: 60

Registration Number: NCT01594697

Locations: 🇮🇹
Catholic University of Sacred Heart, Rome, Italy

Validation of a Laparoscopic Score to Predict the Chance of Optimal Cytoreduction in Advanced Ovarian Cancer Patients

Not Applicable

Completed

Conditions: Cancer of Ovary

Interventions: Procedure: Diagnostic laparoscopy

First Posted Date: 2012-05-09

Last Posted Date: 2012-05-22

Lead Sponsor: Catholic University of the Sacred Heart

Target Recruit Count: 163

Registration Number: NCT01595204

IPHC in Patients With Platinum-sensitive Recurrent Ovarian Cancer

Phase 2

Completed

Conditions: Ovarian Epithelial Cancer Recurrent

Interventions: Procedure: HIPEC

First Posted Date: 2012-05-01

Last Posted Date: 2012-05-01

Lead Sponsor: Catholic University of the Sacred Heart

Target Recruit Count: 30

Registration Number: NCT01588964

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy